The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Luotea Oyj
OMXH:LUOTEA
|
FI |
|
S
|
Spie SA
SWB:4SP
|
FR |
|
Bastide le Confort Medical SA
PAR:BLC
|
FR |
|
Systemair AB
STO:SYSR
|
SE |
|
C
|
CopperCorp Resources Inc
F:NU0
|
CA |
|
ING Groep NV
AEX:INGA
|
NL |
|
Rithm Capital Corp
NYSE:RITM
|
US |
|
JCR Pharmaceuticals Co Ltd
OTC:JCRRF
|
JP |
|
O
|
Oracle Corp Japan
XMUN:OCJ
|
JP |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
Million Health Technology Inc
OTC:BTIM
|
US |
|
M
|
Mitsubishi Corp
OTC:MSBHF
|
JP |
|
C
|
Church & Dwight Co Inc
LSE:0R13
|
US |
|
Telkom Indonesia (Persero) Tbk PT
IDX:TLKM
|
ID |
|
Morgan Stanley
NYSE:MS
|
US |
|
T
|
Thai Parcels PCL
SET:TPL
|
TH |
|
C
|
Celanese Corp
XMUN:DG3
|
US |
|
A
|
Alvopetro Energy Ltd
OTC:ALVOF
|
CA |
Luotea Oyj (LUOTEA)’s 12-month stock price forecast through October 2027 has a consensus target of €2.244, implying 19% upside. The forecast is based on price targets from 4 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for LUOTEA is 2.244 EUR with a low forecast of 2.121 EUR and a high forecast of 2.31 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 53%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next -9 years is 14%.
Over the last 13 years, the compound annual growth rate for Operating Income has been -19%. The projected CAGR for the next 2 years is 286%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -20%. The projected CAGR for the next 2 years is 261%.
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 2 years is -75%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more